This is a routine employee share scheme issuance with negligible dilution. No market-moving implications; monitor upcoming quarterly results for operational performance.
AZN drugs
AZN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 2 $186.58entry
- T+1 · 14d ago −1.45%α −1.75% · $183.88
- T+5 · 8d ago +1.51%α +1.43% · $189.39
- T+10 · todayOpen
- T+20 · in 14d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
AstraZeneca filed a Form 6-K reporting the admission of 11,948 ordinary shares under its employee share schemes, issued between 1 October and 31 October 2026. The total shares outstanding increased to 1,551,065,237. This is a routine administrative notification with no material financial impact.
Key Facts
- 11,948 ordinary shares of $0.25 each were issued and admitted to trading on the London Stock Exchange Main Market.
- Shares were issued under the company's employee share schemes from 1 October 2026 to 31 October 2026.
- Total shares in issue following admission: 1,551,065,237.
- The admission was made under a block admission dated 29 January 2021.
- The newly issued shares are fully fungible with existing ordinary shares.
Financial Impact
Dilution of approximately 0.0008% of outstanding shares (11,948 / 1,551,065,237). Immaterial.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-009359 |
| Document: 0001654954-26-009359-index-headers.html | 0001654954-26-009359 |
| Document: 0001654954-26-009359-index.html | 0001654954-26-009359 |
| Document: 0001654954-26-009359.txt | 0001654954-26-009359 |
| Earnings Context (Synthetic; results releases only) | 0001654954-26-009359 |
Track record
77 reports on AZN
19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
- Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
- Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Viewing Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
- Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
- Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers